Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlaxoSmithKline PLC (NYSE:GSK)

42.28
Delayed Data
As of 4:02pm ET
 -0.04 / -0.09%
Today’s Change
37.20
Today|||52-Week Range
45.58
+9.79%
Year-to-Date
Novartis' Acute Heart Failure Drug Fails in Late-Stage Study
6:47pm / Zacks.com - Paid Partner Content
Lilly's Breast Cancer Combo Drug Phase III Results Positive
Mar 21 / Zacks.com - Paid Partner Content
Jeff Auxier Reduces, Exits Multiple Positions in 4th Quarter
5:00pm / GuruFocus News - Paid Partner Content
Novartis (NVS) Announces Positive Data on Heart Failure Drug
Mar 20 / Zacks.com - Paid Partner Content
Allergan's Dermal Filler for Wrinkle Correction Gets FDA Nod
Mar 21 / Zacks.com - Paid Partner Content
AstraZeneca (AZN) Gets Another CRL for ZS-9; Inks COPD Deal
Mar 20 / Zacks.com - Paid Partner Content
Still Bullish on GlaxoSmithKline
Mar 21 / TheStreet.com - Paid Partner Content
Why Biotech Stock Gilead (GILD) Could Be a Value Trap
Mar 20 / Zacks.com - Paid Partner Content
6 Reasons to Invest in GlaxoSmithKline (GSK) Stock in 2017
Mar 21 / Zacks.com - Paid Partner Content
Glaxo Files for Label Expansion of Influenza Vaccine in US
Mar 16 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close42.32
Today’s open42.26
Day’s range42.15 - 42.42
Volume2,071,561
Average volume (3 months)3,722,086
Market cap$104.0B
Dividend yield4.75%
Data as of 4:02pm ET, 03/22/2017

Growth & Valuation

Earnings growth (last year)-90.48%
Earnings growth (this year)+9.05%
Earnings growth (next 5 years)+11.22%
Revenue growth (last year)+2.85%
P/E ratio377.5
Price/Sales2.52
Price/Book74.17

Competitors

 Today’s
change
Today’s
% change
ABBVAbbVie+0.17+0.26%
CELGCelgene-0.45-0.36%
SNYSanofi+0.31+0.70%
BMYBristol-Myers Squibb+0.65+1.17%
Data as of 4:01pm ET, 03/22/2017

Financials

Next reporting dateApril 26, 2017
EPS forecast (this quarter)$0.64
Annual revenue (last year)$37.5B
Annual profit (last year)$1.2B
Net profit margin3.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Executive Director
Andrew Philip Witty
Chief Financial Officer &
Executive Director
Simon Dingemans
Corporate headquarters
Brentford, Greater London

Forecasts


Search for Jobs